Condition
HIV I Infection clinical trials and research
As of November 12, 2026, Find a Trial lists 6 HIV I Infection clinical trials that are recruiting, at sites in 7 countries (most in Brazil (2), France (2), South Africa (1)). By phase: Phase 2 (3), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 7Countries
Newest HIV I Infection clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Comparing pain from HIV injections using different sites and virtual reality | — | Orléans, Loiret and 4 other locations | Recruiting | Feb 19, 2025 |
| Strategies to reduce HIV reservoirs to help remission without daily meds | Phase 2 | São Paulo, São Paulo | Recruiting | Feb 3, 2025 |
| Use of Lenacapavir for HIV-1 treatment in France | — | Paris, Île-de-France Region | Recruiting | Jan 29, 2025 |
| Evaluating the safety and immune response of MTBVAC in adolescents and adults with and without HIV in South Africa | Phase 2 | Johannesburg, Gauteng and 15 other locations | Recruiting | Jul 17, 2023 |
| Using adalimumab to improve survival in HIV patients with tuberculosis meningitis | Phase 2 | Rio de Janeiro and 2 other locations | Recruiting | Oct 21, 2022 |
| Low dose Nivolumab treatment for adults with HIV on antiretroviral therapy | Phase 1/2 | Melbourne, Victoria and 1 other locations | Recruiting | Jan 11, 2022 |
All recruiting trials (6)
-
Comparing pain from HIV injections using different sites and virtual reality
This study is testing whether using virtual reality during HIV injections can help reduce pain for patients receiving antiretroviral treatments.
-
Strategies to reduce HIV reservoirs to help remission without daily meds
This study tests a combination approach to see if intensified antiretroviral therapy, a special latency-breaking drug, a cell therapy vaccine, and other agents can shrink HIV reservoirs in people on stable ART.
-
Use of Lenacapavir for HIV-1 treatment in France
This study is testing how well Lenacapavir works as an additional treatment for adults in France who have a tough-to-treat form of HIV-1.
-
Evaluating the safety and immune response of MTBVAC in adolescents and adults with and without HIV in South Africa
This study is testing the MTBVAC vaccine to see if it's safe and effective for adolescents and adults in South Africa, both with and without HIV, by comparing it to the BCG vaccine.
-
Using adalimumab to improve survival in HIV patients with tuberculosis meningitis
This study is testing if adding a medication called adalimumab to the usual treatment can help HIV patients with tuberculosis meningitis live longer and stay safe.
-
Low dose Nivolumab treatment for adults with HIV on antiretroviral therapy
This study is testing if a low dose of Nivolumab can help adults with HIV on medication reduce the virus in their bodies and possibly stop their HIV treatment safely.
Related topics
Quick answers
How many HIV I Infection clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in Brazil (2 trials), France (2 trials), South Africa (1 trial), Australia (1 trial), Singapore (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.